This is a preview of subscription content, log in via an institution to check access.
References
, et al. Aflibercept not cost effective for CRC, says NICE PharmacoEconomics and Outcomes News : 11, No. 700, 12 Mar 2014
NICE. NICE guidance supports new device for managing wounds. Media Release : 25 Mar 2014. Available from: URL: http://www.nice.org.uk
NICE. NICE issues final guidance aflibercept for colorectal cancer. Media Release : 25 Mar 2014. Available from: URL: http://www.nice.org.uk
NICE. NICE says yes to new treatment for rare autoimmune disease in final guidance. Media Release : 25 Mar 2014. Available from: URL: http://www.nice.org.uk
NICE. NICE set not to recommend ustekinumab for psoriatic arthritis. Media Release : 27 Mar 2014. Available from: URL: http://www.nice.org.uk
NICE. NICE recommends tests to help diagnose and manage asthma. Media Release : 2 Apr 2014. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
Aflibercept not cost effective for CRC, says NICE. PharmacoEcon Outcomes News 700, 11 (2014). https://doi.org/10.1007/s40274-014-1180-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1180-9